Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2/3
×
abiraterone
×
Clear all
Filters
2
NCT00268476
2023-04-18
STAMPEDE
Medical Research Council
Phase 2/3
Active not recruiting
11,992 enrolled
NCT03295565
2022-04-15
OSTRICh
The Netherlands Cancer Institute
Phase 2/3
Completed
100 enrolled